JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares NASDAQ

Last close $222.45 as of 08 Oct 2026

Avg call return: −11.3%; −13.9% vs. index
Scored calls: 3
Channels: 2
Win Rate: 0%
Side taken: 3Buy 0Sell

3 scored calls · 2 channels · first tracked 27 Jul 2026

JAZZ: tracked call record. Across the full tracked record, 3 of 3 published calls are scored, with an average call return of -11.34%. Scored calls were published from 27 Jul 2026 to 20 Aug 2026, measured from each entry price to its latest available close (price dates: 08 Oct 2026 to 08 Oct 2026). Average benchmark excess is -13.90 percentage points, based on 3 of the 3 scored calls only. Unscored calls are excluded from averages. Holding periods and price freshness vary. These are averages of directional call returns, not an investable portfolio return; fees, dividends and execution costs are not included.

Who is calling JAZZ

Last 12 months · 2 buying · 0 selling

01 Fox Business Clips Buy Calls 1 Return −10.6% Show calls
1. 20 Aug 2026 Buy Entry $248.70 Now $222.45 −10.6% vs. index −12.0%
  AI-extracted call. Cite this call
  
  I HOPE SO, TEN TIMES EARNINGS. GREAT HIGHFLYING OF ONCOLOGY DRUGS, A BIG ANNOUNCEMENT ON THE 20th OF AUGUST, WHICH WE ARE LOOKING FORWARD TO, FDA APPROVAL.
Full record for Fox Business Clips
02 WallStreetZen Buy Calls 2 Return −11.7% Show calls
1. 20 Aug 2026 Buy Entry $248.70 Now $222.45 −10.6% vs. index −12.0%
  AI-extracted call. Cite this call
  
  This is why Wall Street pros and the Zacks Earnings are all pounding the table for a lot more upside in the months and years ahead.
2. 27 Jul 2026 Buy Entry $255.43 Now $222.45 −12.9% vs. index −17.6%
  AI-extracted call. Cite this call
  
  This is a quality value setup that might be the right prescription for your portfolio.
Full record for WallStreetZen